Halozyme Therapeutics Inc.

(HALO) Trade

By |

Profile

Halozyme Therapeutics Inc is a biotechnology company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.

Contact Information

Website: www.halozyme.com
Email: ir@halozyme.com
Main Phone: +1 858 794-8889
Address: 11388 Sorrento Valley Road
Address 2: Unit 200
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NGS
CEO: Helen I. Torley
Employees: 255
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 17.88 $ 0.35 (2.00%)
Last Price 17.88 Change $ 0.35 Change % 2.00 Tick N/A
Bid 17.88 Bid Size 200.00 Ask 17.89 Ask Size 400.00
Open 17.50 High 17.92 Low 17.42 Prev Close 17.53
Last Trade Volume 385,686 52 Wk Hi 21.48 52 Wk Low 16.06
Market Cap 2.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 144,304,240.00 EPS (TTM) 0.57 PE Ratio 30.80 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 10 31
Number of Buys 8 20
Number of Sells 2 11
Net Activity 68007 -1263509
Last 10 Buys Shares
Laurie Stelzer 1,000
Kathryn E. Falberg 1,000
Kathryn E. Falberg 1,000
Robert L. Engler 1,000
James P. Shaffer 1,000
Kathryn E. Falberg 1,000
Kenneth J. Kelley 1,000
Gregory I. Frost 1,000
Randal J. Kirk 1,000
Randal J. Kirk 1,000
Last 10 Sell Shares
Kenneth J. Kelley 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Kenneth J. Kelley 1,000
Robert L. Engler 1,000
Robert L. Engler 1,000
John S. Patton 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 33 33 33 33
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 20.17 20.17 20.17 20.17
Standard Deviation 7.7 7.7 7.7 7.7
Date of Most Recent Estimate 05/11/18 05/11/18 05/11/18 05/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 5 5
Moderate Buy 0 0 0 0
Hold 1 1 3 3
Moderate Sell 1 1 1 1
Strong Sell 1 1 0 0
Mean Rec. 2.5 2.5 2 2